In these retrospective studies, Triple-negative status, Lymphovascular invasion, Ki67 30%, and High GSH intake were identified as independent risk factors for poor postoperative prognosis in breast cancer chemotherapy patients
11 Preliminary data for the SULF-FAST clinical decision tool have been promising, with high specificity and negative predictive value
After this time, the toxic substance may no longer be in the stomach, and the treatment may be ineffective
Side effects: Nausea (take with food if occurs) Sulfur smell (normal) Rare: rash, wheezing (discontinue if allergic) Expected timeline: Noticeable improvements in energy, skin quality, and recovery within 2-4 weeks
Timing Baseline Monitoring guidance is IGF-pathway-based because IGF-1 LR3 does not have established routine clinical monitoring standards
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure